A Phase III, Randomised, Controlled Trial for the Treatment of HIV-Associated Cryptococcal Meningitis: Oral Fluconazole Plus Flucytosine or One Week Amphotericin B-Based Therapy vs Two Weeks Amphotericin B-based Therapy, p.45035509, 2013. ,
Preheating of urine improves the specificity of urinary cryptococcal antigen testing using the lateral flow assay, PLOS Neglected Tropical Diseases, vol.16, issue.10, 2017. ,
DOI : 10.1371/journal.pntd.0005304.t001
Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV, Cochrane Database Syst. Rev, vol.20, 2005. ,
Epidemiology of HIV-associated cryptococcosis in France (1985???2001), AIDS, vol.18, issue.3, pp.555-562, 1985. ,
DOI : 10.1097/00002030-200402200-00024
Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults, AIDS, vol.16, issue.7, pp.1031-1038, 2002. ,
DOI : 10.1097/00002030-200205030-00009
Activite de Lutte Contre le VIH, SIDA et Les IST au Cameroun: Rapport Annuel 2015. Antananarivo: Comite National de Lutte contre le VIH/SIDA, 2015. ,
, CrAg LFA Norman Available at: http://www. immy.com/products/lateral-flow-assays/crag-lfa, IMMY, 2017.
: Cryptococcosis in AIDS: New Data but Questions Remain, Clinical Infectious Diseases, vol.62, issue.5, pp.588-589, 2016. ,
DOI : 10.1093/cid/civ936
Cryptococcal Antigen Screening and Preemptive Therapy in Patients Initiating Antiretroviral Therapy in Resource-Limited Settings, Journal of the International Association of Physicians in AIDS Care, vol.53, issue.4, pp.374-379, 2012. ,
DOI : 10.1093/cid/cir379
Cost Effectiveness of Cryptococcal Antigen Screening as a Strategy to Prevent HIV-Associated Cryptococcal Meningitis in South Africa, PLoS ONE, vol.99, issue.10, 2013. ,
DOI : 10.1371/journal.pone.0069288.s001
Screening for Cryptococcal Antigenemia in Patients Accessing an Antiretroviral Treatment Program in South Africa, Clinical Infectious Diseases, vol.48, issue.7, pp.856-862, 1086. ,
DOI : 10.1086/597262
Six-month outcomes of HIV-infected patients given short-course fluconazole therapy for asymptomatic cryptococcal antigenemia, AIDS, vol.29, issue.18, pp.2473-2478, 2015. ,
DOI : 10.1097/QAD.0000000000000872
Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa, AIDS, vol.22, issue.15, pp.1897-1908, 2008. ,
DOI : 10.1097/QAD.0b013e32830007cd
URL : https://hal.archives-ouvertes.fr/inserm-00266588
Cryptococcal antigenemia in immunocompromised human immunodeficiency virus patients in rural Tanzania: a preventable cause of early mortality. Open Forum Infect. Dis. 2:ofv046. doi: 10 Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda, Trop. Med. Int. Health, vol.12, pp.929-935, 1093. ,
, , 2016.
Cell Count ???100 Cells/??L Who Start HIV Therapy in Resource???Limited Settings, Cryptococcal antigen screening in patients initiating ART in South Africa: a prospective cohort study, pp.581-587, 1086. ,
DOI : 10.1086/655143
Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial, The Lancet, vol.385, issue.9983, pp.2173-2182, 2015. ,
DOI : 10.1016/S0140-6736(15)60164-7
, Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients, 2007.
, J. Acquir. Immune Defic. Syndr, vol.45, pp.555-559
Cost-Effectiveness of Primary Prophylaxis of AIDS Associated Cryptococcosis in Cambodia, PLoS ONE, vol.43, issue.11, 2010. ,
DOI : 10.1371/journal.pone.0013856.s001
The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, Clin. Infect. Dis, vol.3636, pp.789-794, 1086. ,
Pre-art cryptococcal antigen titer associated with preemptive fluconazole failure, Proceedings of the Conference on Retroviruses and Opportunistic Infections, p.64, 2016. ,
Implementation and Operational Research, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.68, issue.5, 2015. ,
DOI : 10.1097/QAI.0000000000000527
, Immune Defic. Syndr, vol.68, pp.69-76
Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial, The Lancet Infectious Diseases, vol.11, issue.12, pp.933-941, 2011. ,
DOI : 10.1016/S1473-3099(11)70245-6
HIV care: ART adherence support and cryptococcal screening, The Lancet, vol.385, issue.9983, pp.2128-2129, 2015. ,
DOI : 10.1016/S0140-6736(15)60455-X
Integrating Cryptococcal Antigen Screening and Pre-Emptive Treatment into Routine HIV Care, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.59, issue.5, 2012. ,
DOI : 10.1097/QAI.0b013e31824c837e
URL : http://europepmc.org/articles/pmc3311156?pdf=render
, J. Acquir. Immune Defic. Syndr, vol.59, pp.85-91
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis, The Lancet Infectious Diseases, vol.17, issue.8, pp.873-881, 2017. ,
DOI : 10.1016/S1473-3099(17)30243-8
A Prospective Longitudinal Study of the Clinical Outcomes from Cryptococcal Meningitis following Treatment Induction with 800 mg Oral Fluconazole in Blantyre, Malawi, PLoS ONE, vol.53, issue.(1), 2013. ,
DOI : 10.1371/journal.pone.0067311.t002
Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa: a meta-analysis Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program? Vietnam, Clin. Infect. Dis. PLoS One, vol.60, issue.8, pp.1120-1127, 2002. ,
Comparison of a Novel Semi-Quantitative Prototype and a Commercial Lateral Flow Assay for Detection of Cryptococcal Antigen from Thawed Whole Blood Samples, 2016. ,
, Rapid Advice: Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-Infected Adults, Adolescents and Children, World Health Organization Geneva: WHO, 2011.
, Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach, World Health Organization, 2016.